Please Note: This trial is no longer enrolling new participants
A Phase II Study of the Combination of Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Relapsed Hodgkin Lymphoma (HL) and B-Non-Hodgkin-lymphoma (B-NHL)
Protocol No. | CTO-IUSCCC-0866 | Scope | Local |
---|---|---|---|
Principal Investigator | Rita Assi | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase II |